I listened to the call. There will definitely not be a reverse split for a while/ever. Too much hassle and complications if the share price does not hold after split price for 30 days. Just forget about the RS.
His goal is to sell the company down the road. Short term he is opened/look for a partnership, but only if the price/deal is right. He will NOT do a deal if the price/valuation is not in line with the future potential of the company. From what he said, it looks like they are talking to potential partners, he could obviously not say who/how many, but it may or may not come to fruition. They will need future financing (especially if no partner) down the road and the plan is to do the financing at a higher price based on news coming up in the next few months/quarters.
Medicine (I am not an expert so below are some notes I took, hopefully someone with science background can add more).
Dual: they will only need 30 patients. I do not believe they have too many patients enrolled at the moment but he seemed confident they will enrol 30 patients in the short term now that they cleared FDA hurdle/meeting. Need 24 weeks after injecting the 30th patient to conclude this step. Expect last patient enrolled by Q1. The downside of the reduction to 30 means that it will not be enough to get FDA approval for safety. That will be resolved by using a number of patients from Mono. He seems very confident that they will meet FDA requirements for Dual (do not ask me what they are but he did mention), based on past results which were way above/better than FDA minimal requirements.
Mono: still need 300 patients but he believes that number may/will come down after more FDA discussions to be held at a later stage. They have some work to do on the planning of the mono. Some patients failed (not sure exactly what/why) before so they need to work on selecting the right patients. Again, I believe they are early stage of enrolling. He believes it will be quicker to enrol once they sort out the selection/screening process and other steps before going ahead with next phase.
He has videos (cannot put them up on the company site) with testimonies from patients who have been on other medicine for 10-20 years and are now with CYDY and they said it was life changing event for them. So looks like the science is working, just need to put everything together and more time needed.
A doctor named Scott Kelly called. He was very knowledgeable. Hopefully he is on this board as he knows the science behind CYDY. He could add more valuable comments re science and next steps with FDA.
Hope this helps.
AR
News 
Market Data 
Discover 
